GO
Loading...

Merck & Co Inc

More

  • Merck Shares Gain as Earnings Top Estimates Monday, 21 Apr 2008 | 7:54 AM ET

    Merck said first-quarter profit rose on gains from a deal with longtime partner AstraZeneca, although the company's sales rose only 1 percent as negative results of a clinical trial slowed growth of its Vytorin and Zetia cholesterol drugs.

  • Futures Dip, Hurt by National City Cash Plan Monday, 21 Apr 2008 | 7:02 AM ET

    Stock index futures pointed to a lower start for the week as the first wave in a big week of earnings reports left investors wary.

  • Week Ahead: The Big Test Friday, 18 Apr 2008 | 8:09 PM ET

    Whenever the stock market rushes full speed ahead, it is hard not to look for the big let-down. That could be the case in the week ahead... Major earnings reports, housing data, annual shareholder meetings, and Tuesday's Pennsylvania presidential primaries are what traders will be watching to see if the trend continues.

  • Dollar's Rebound Tied to Hopes for US Economy Friday, 18 Apr 2008 | 3:55 PM ET
    Exchanging Dollars and Euros

    Signs of renewed confidence in the U.S. financial system could support the dollar next week, provided March's housing reports do not revive chances of a steep interest rate cut.

  • Pfizer Profit Slips, Hurt by Generic Drugs Thursday, 17 Apr 2008 | 9:40 AM ET

    Pfizer on Thursday reported a worse-than-expected decline in first-quarter earnings after declining sales of cholesterol fighter Lipitor and medicines now facing generic competition, sending shares down almost 4 percent.

  • Stocks Rally to the End; Intel Powers Techs Wednesday, 16 Apr 2008 | 4:53 PM ET

    Stocks finished at their highs for the day Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan.

  • Stocks Rebound After 'Beige' Mood Swing Wednesday, 16 Apr 2008 | 3:08 PM ET

    Stocks rose sharply Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan Chase.

  • Merck Misrepresented Vioxx Data: JAMA Report Tuesday, 15 Apr 2008 | 3:47 PM ET

    A new report in the Journal of the American Medical Association is highly critical of drugmaker Merck and its handling of the painkiller Vioxx.

  • AstraZeneca Shares Leap on Nexium Settlement Deal Tuesday, 15 Apr 2008 | 5:50 AM ET

    AstraZeneca has settled U.S. patent litigation against India's Ranbaxy Laboratories over its top-selling drug, ulcer pill Nexium, securing future sales and sending its shares soaring.

  • Lightning Round: Motorola, Pfizer, Boeing and More Friday, 11 Apr 2008 | 6:31 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Lightning Round: Yahoo, Petrobras, Ambac and More Thursday, 10 Apr 2008 | 6:35 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • CBOE Volatility Close to Low for the Year Thursday, 10 Apr 2008 | 12:37 PM ET

    With good news from Walmart and Goldman CEO Blankfein saying we are closer to the end of the current financial crisis than the beginning, the markets are rallying. Is Blankfein right or is it the calm before the storm?

  • MannKind Being Its Own "Man" About Inhalable Insulin Thursday, 10 Apr 2008 | 12:22 PM ET

    This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few.

  • Merck: Cramer's No. 1 Dow Stock Wednesday, 9 Apr 2008 | 7:08 PM ET

    He's expecting a full recovery – and more – for this company.

  • CNBC and other media outlets have done a significant amount of reporting on cardiologists' reaction to the Vytorin/Zetia study and the effect the ACC panel's opinion might have on the heart doctors' prescription writing.

  • Stocks End Lower On WaMu, Fed Minutes Tuesday, 8 Apr 2008 | 3:08 PM ET

    Stocks closed lower amid more bad news in the financial sector and a report showing the Federal Reserve is more worried about a recession than it has previously indicated.

  • Your First Move For Monday Apr. 7th Friday, 4 Apr 2008 | 7:09 PM ET

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • My Merck/Schering-Plough Coverage Draws Your Emails Friday, 4 Apr 2008 | 5:02 PM ET

    This week started out with Merck shares suffering their worst loss since the day the drugmaker recalled Vioxx and Schering-Plough shares posting their worst one-day decline ever. But yesterday, SGP had its biggest percentage gain in eight years and today it's finishing the week as the sector's biggest percentage gainer.

  • Merrill News Helps Keep Stocks Afloat Thursday, 3 Apr 2008 | 4:51 PM ET

    Stocks logged another lackluster session Thursday in the wake of Tuesday's spectacular rally as the market digested a mixed bag of economic data and a congressional hearing on the Bear Stearns bailout.

  • Rally Fizzles as Oil Creeps Up Near $105 Wednesday, 2 Apr 2008 | 5:02 PM ET

    Stocks finished slight lower Wednesday as the financial-driven rally that kicked off the quarter Tuesday lost steam. Energy, retail and chips finished mostly higher.